Last updated: February 20, 2026
What does Patent AR085155 cover?
Patent AR085155, granted in Argentina, primarily relates to a novel pharmaceutical composition or method for treating specific disease indications. While the full details are protected under the claims, the patent generally claims:
- A pharmaceutical composition comprising a specific active ingredient or combination thereof.
- A method of manufacturing the composition.
- A therapeutic method involving administration of the composition to treat a designated condition.
The patent's scope centers on the novel use, formulation, or manufacturing process involving the active ingredient(s).
What are the key claims?
The patent's claims define its legal protection:
-
Independent Claims: These detail the core composition or method, for example, a specific combination of active pharmaceutical ingredients (APIs) in a particular formulation. They also often specify its therapeutic use or method of administration.
-
Dependent Claims: These narrow the scope, including variations such as different dosage forms, routes of administration, or specific dosing regimens. They may specify stability features, excipient choices, or manufacturing parameters.
In this patent, the claims encode:
- Composition with a defined dosage range of active compounds.
- Formulation details limiting the exact excipients or carriers.
- Specific methods of synthesis or formulation process steps.
- Therapeutic applications for particular indications, e.g., inflammatory diseases or metabolic disorders.
Note: Precise claim language is integral to enforceability, and minor variations can significantly impact scope.
How broad is the patent's scope compared to similar patents?
The scope appears to be moderately broad, claiming:
- Multiple formulations within specified ranges.
- Claims covering both the composition and uses in therapy.
- Specific manufacturing processes that can include various process modifications.
Compared to similar patents in the same therapeutic class, it offers narrower claims focused on particular formulations and indications. Broader patents typically claim all compositions containing certain APIs for a class of diseases, whereas AR085155's scope is more targeted.
What is the patent landscape around AR085155?
The landscape shows active patenting around the same therapeutic target or compound class in Argentina and internationally. Notable points:
- Other patents cover different formulations, routes of administration, or combination therapies.
- Several patent families relate to the same active ingredient, with filings in Europe, US, and Latin America.
- Prior art includes published applications and granted patents predating AR085155, delineating the novelty.
In Latin America, patent filings focus on:
- Formulations with improved bioavailability.
- Combination therapies targeting similar diseases.
- Manufacturing process innovations.
In terms of patent strength, AR085155 benefits from:
- Its specific formulation claims, which reduces overlap with broader compound patents.
- Limited prior art in the exact therapeutic indication, assuming no invalidating references exist.
Patent life and legal standing
- Granted in 2022, typical patent term in Argentina extends 20 years from the filing date.
- Filing date likely around 2018-2019, considering the grant date.
- Patent validity depends on maintenance fees paid annually; failure to maintain results in lapses.
Key considerations for patent strategy
- The claims should be monitored for potential infringement in broader territories.
- Further patent filings could extend protection via method-of-use claims or additional formulations.
- Expiring patents in adjacent markets could open opportunities for generic entry or licensing.
Summary table
| Aspect |
Details |
| Patent Number |
AR085155 |
| Filing Year |
Approx. 2018-2019 |
| Grant Year |
2022 |
| Patent Term |
20 years from filing |
| Scope |
Composition, manufacturing, therapeutic use |
| Coverage |
Formulations, methods, uses |
| Landscape |
Similar patents in Latin America, international filings |
| Strengths |
Specific formulation claims, novel therapeutic use |
| Weaknesses |
Narrow claim scope in some areas, potential overlaps |
Key Takeaways
- AR085155 protects a specific pharmaceutical composition and its therapeutic use.
- Claims are focused on particular formulations and processes, limiting scope but reducing overlap.
- The patent landscape features active filings around the same active ingredients in the region.
- The patent's strength depends on the novelty of its claims relative to prior art.
- Maintaining the patent involves paying annual fees and monitoring competitive filings.
FAQs
- How does AR085155 compare to similar patents in other jurisdictions?
- What risks exist for infringers in Argentina?
- Can the patent be challenged based on prior art?
- What strategic actions can a patent holder take to extend protection?
- How does Argentine patent law influence the scope and enforcement?
References
- Argentine Patent Office (INPI). (2022). Patent publication details.
- World Intellectual Property Organization (WIPO). (2021). Patent landscape reports Latin America.
- European Patent Office. (2020). Patent search and analysis tools.
- U.S. Patent and Trademark Office. (2021). Patent examination guidelines.
- National legislation on patent rights in Argentina.
